Evidence map›Paper›PMID 23752206›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2013

An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.

Joseph E Doherty, Lauren E Woodard, Adham S Bear, Aaron E Foster, Matthew H Wilson

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joseph E DohertyMedical Scientist Training Program, Baylor College of Medicine, Houston, Texas 77030, USA.
Lauren E Woodard
Adham S Bear
Aaron E Foster
Matthew H Wilson
Baylor College of Medicine · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007330 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 1985 to 2019
$15.6M
Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
Training In Cell and Gene TherapyT32HL092332 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MALCOLM K. BRENNER, Bruno Di Stefano · 2008 to 2026
$6.9M
Novel cell therapy for sustained therapeutic protein delivery in vivoR01DK093660 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, MATTHEW H · 2012 to 2022
$3.4M
Research Training in Renal DiseasesT32DK062706 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MITCH, WILLIAM EVANS · 2003 to 2013
$1.5M
Training in Cell and Gene TherapyT32DK064717 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HESLOP, HELEN E · 2003 to 2007
$880k
NHLBI NIH HHS T32 HL092332NIDDK NIH HHS R01 DK093660NIDDK NIH HHS T32 DK060445NIDDK NIH HHS T32DK060445NIDDK NIH HHS T32 DK062706NIDDK NIH HHS T32DK062706NIDDK NIH HHS T32 DK064717NIDDK NIH HHS T32DK064717NIGMS NIH HHS T32 GM007330NIGMS NIH HHS T32GM007330
6 · The paper itself

Abstract

Transposons permit permanent cellular genome engineering in vivo. However, transgene expression falls rapidly postdelivery due to a variety of mechanisms, including immune responses. We hypothesized that delaying initial transgene expression would improve long-term transgene expression by using an engineered piggyBac transposon system that can regulate expression. We found that a 2-part nonviral Tet-KRAB inducible expression system repressed expression of a luciferase reporter in vitro. However, we also observed nonspecific promoter-independent repression. Thus, to achieve temporary transgene repression after gene delivery in vivo, we utilized a nonintegrating version of the repressor plasmid while the gene of interest was delivered in an integrating piggyBac transposon vector. When we delivered the luciferase transposon and repressor to immunocompetent mice by hydrodynamic injection, initial luciferase expression was repressed by 2 orders of magnitude. When luciferase expression was followed long term in vivo, we found that expression was increased >200-fold compared to mice that received only the luciferase transposon and piggyBac transposase. We found that repression of early transgene expression could prevent the priming of luciferase-specific T cells in vivo. Therefore, transient transgene repression postgene delivery is an effective strategy for inhibiting the antitransgene immune response and improving long-term expression in vivo without using immunosuppression.

Indexed as

AnimalsDNA Transposable ElementsFluorescent Antibody TechniqueGene Transfer TechniquesHeLa CellsHumansImmunoblottingMiceTransgenesTransposasesDNA Transposable ElementsTransposasesgene transferinducible expressionpiggyBac

Identifiers

PMID23752206
PMCPMC3752539
OpenAlexW2111301399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.